Using serial analysis of gene expression on cultured human keratinocytes we found high expression levels of genes putatively involved in host protection and defense, such as proteinase inhibitors and antimicrobial proteins. One of these expressed genes was the recently discovered cysteine proteinase inhibitor cystatin M/E that has not been characterized so far at the protein level with respect to tissue distribution and additional biologic properties. Here we report that cystatin M/E has a tissue-speci®c expression pattern in which high expression levels are restricted to the stratum granulosum of normal human skin, the stratum granulosum/spinosum of psoriatic skin, and the secretory coils of eccrine sweat glands. Low expression levels were found in the nasal cavity. The presence of cystatin M/E in skin and the lack of expression in a variety of other tissues was veri®ed both at the protein level by immunohistochemistry or western blotting, and at the mRNA level by reverse transcriptase polymerase chain reaction or northern blotting. Using biotinylated hexapeptide probes we found that cystatin M/E is an ef®cient substrate for tissue type transglutaminase and for transglutaminases extracted from stratum corneum, and that it acts as an acyl acceptor but not as an acyl donor. Western blot analysis showed that recombinant cystatin M/E could be cross-linked to a variety of proteins extracted from stratum corneum. In vitro, we found that cystatin M/E expression in cultured keratinocytes is upregulated at the mRNA and protein level, upon induction of differentiation. We demonstrate that cystatin M/E, which has a putative signal peptide, is indeed a secreted protein and is found in vitro in culture supernatant and in vivo in human sweat by enzyme-linked immunosorbent assay or western blotting. Cystatin M/E showed moderate inhibition of cathepsin B but was not active against cathepsin C. We speculate that cystatin M/E is unlikely to be a physiologically relevant inhibitor of intracellular lysosomal cysteine proteinases but rather functions as an inhibitor of self and nonself cysteine proteinases that remain to be identi®ed.
Using serial analysis of gene expression on cultured human keratinocytes we found high expression levels of genes putatively involved in host protection and defense, such as proteinase inhibitors and antimicrobial proteins. One of these expressed genes was the recently discovered cysteine proteinase inhibitor cystatin M/E that has not been characterized so far at the protein level with respect to tissue distribution and additional biologic properties. Here we report that cystatin M/E has a tissue-speci®c expression pattern in which high expression levels are restricted to the stratum granulosum of normal human skin, the stratum granulosum/spinosum of psoriatic skin, and the secretory coils of eccrine sweat glands. Low expression levels were found in the nasal cavity. The presence of cystatin M/E in skin and the lack of expression in a variety of other tissues was veri®ed both at the protein level by immunohistochemistry or western blotting, and at the mRNA level by reverse transcriptase polymerase chain reaction or northern blotting. Using biotinylated hexapeptide probes we found that cystatin M/E is an ef®cient substrate for tissue type transglutaminase and for transglutaminases extracted from stratum corneum, and that it acts as an acyl acceptor but not as an acyl donor. Western blot analysis showed that recombinant cystatin M/E could be cross-linked to a variety of proteins extracted from stratum corneum. In vitro, we found that cystatin M/E expression in cultured keratinocytes is upregulated at the mRNA and protein level, upon induction of differentiation. We demonstrate that cystatin M/E, which has a putative signal peptide, is indeed a secreted protein and is found in vitro in culture supernatant and in vivo in human sweat by enzyme-linked immunosorbent assay or western blotting. Cystatin M/E showed moderate inhibition of cathepsin B but was not active against cathepsin C. We speculate that cystatin M/E is unlikely to be a physiologically relevant inhibitor of intracellular lysosomal cysteine proteinases but rather functions as an inhibitor of self and nonself cysteine proteinases that remain to be identi®ed. Key words: cathepsins/cysteine proteinases/eccrine glands/ endopeptidases/hair follicle. J Invest Dermatol 116:693± 701, 2001 C ystatins are natural and speci®c inhibitors of endogenous mammalian lysosomal cysteine proteinases, such as cathepsins B, L, H, and S (Turk and Bode, 1991; Abrahamson, 1994) , and exogenous microbial cysteine proteinases (Bjorck, 1990) . Several studies have indicated that cystatins provide important regulatory and protective functions against uncontrolled proteolysis by cysteine proteinases from host, bacterial, and viral origin (Bobek and Levine, 1992) . A disturbed balance between proteinases and their inhibitors can lead to irreversible damage as in chronic in¯ammatory reactions (Henskens et al, 1996) and tumor metastasis (Calkins and Sloane, 1995) . In addition to their proteinase inhibitory activity, some of the cystatins (C and S) were shown to have antimicrobial activity against bacteria (Bjorck et al, 1989; Blankenvoorde et al, 1998) and viruses (Korant et al, 1986; Bjorck et al, 1990) . Cystatins are members of a superfamily of evolutionary related proteins and can be divided into three major families (Rawlings and Barrett, 1990) : family 1 cystatins A and B (or stef®ns A and B), family 2 cystatins (C, D, S, SN, and SA), and the kininogens, which belong to family 3 cystatins. A new member of the human cystatin superfamily, named cystatin M, was recently identi®ed and characterized (Sotiropoulou et al, 1997) . The gene was identi®ed by differential display, comparing mRNAs from primary and metastatic breast tumor cells, and was found to be downregulated in metastatic cells. The same cystatin was independently found by expressed sequence tag sequencing in epithelial-cell-derived cDNA libraries and reported as cystatin E (Ni et al, 1997) . Cystatin M/E is a 14 kDa protein that shares a 35% homology with the human family 2 cystatins, has similar overall structures, such as signal peptide and two intrachain disul®de bonds, but possesses the unusual characteristic of being a glycoprotein. Cystatin M/E proved to be a potent inhibitor of papain and cathepsin B (Ni et al, 1997; Sotiropoulou et al, 1997) , although speci®c physiologic functions or target molecules have not been reported so far. Cystatin M/E was reported to have a broad tissue distribution at the mRNA level, although the reports of Ni et al and Sotiropoulou et al gave con¯icting results. No tissue localization studies at the protein level have been reported to date.
Epithelial tissues serve as a ®rst line of defense between the host and the environment. Disturbance of this barrier can lead to the invasion of microbial pathogens and subsequent in¯ammation. Previous studies have shown that epithelia that are subjected to continuous microbial stress or in¯ammatory stimuli (e.g., oral epithelia, trachea, skin) express several proteins that provide protection against microbial pathogens and excessive proteolysis by endogenous and exogenous proteinases. These proteins have been assigned as a key component of the innate immune system (Boman, 1998; Lehrer and Ganz, 1999) , a system that can be triggered by infection and protects the host organism against invading microorganisms (Medzhitov and Janeway, 1998) . Recently, several proteins that are involved in protection against tissue damage were found to be expressed in human skin in response to in¯ammatory events. These proteins include two wellcharacterized serine proteinase inhibitors with antimicrobial properties, secretory leukocyte proteinase inhibitor (SLPI) (Hiemstra et al, 1996; Wiedow et al, 1998; Wingens et al, 1998) and skin-derived antileukoproteinase (SKALP)/ela®n (Simpson et al, 1999) , a member of the trappin gene family (Zeeuwen et al, 1997; Schalkwijk et al, 1999) . Both proteins are originally described as inhibitors of polymorphonuclear leukocyte derived enzymes, like human neutrophil elastase, that are secreted under in¯ammatory conditions of the skin (e.g., wound healing, psoriasis) (Thompson and Ohlsson, 1986; Schalkwijk et al, 1990; Wiedow et al, 1990; Molhuizen et al, 1993; Pfundt et al, 1996) .
Much of the barrier function of human epidermis against the environment is provided by the corni®ed cell envelope (CE) (Robinson et al, 1997; Nemes and Steinert, 1999) , which is assembled by transglutaminase (TGase) cross-linking of several structural proteins, like small proline-rich proteins, loricrin, cytokeratins, ®laggrin, and involucrin (Steinert and Marekov, 1995) . Two epidermal proteinase inhibitors were found to be anchored to structural proteins of the stratum corneum. SKALP/ ela®n was found in foreskin by direct protein sequencing (Steinert and Marekov, 1997) , and cystatin A, the only member of the cystatin family so far that has been found in human epidermis, was shown to be part of the CE and acts as a TGase substrate (Takahashi et al, 1996) .
Recently we have started with the construction of a transcriptome of human epidermis using serial analysis of gene expression (SAGE). Using SAGE we have made an extensive expression pro®le of cultured human keratinocytes, comprising over 25,000 sequenced tags (Jansen et al, 2001) . From this analysis it was clear that genes involved in host protection and host defense (proteinase inhibitors and antimicrobial proteins) were expressed at high levels. Cystatin M/E, not previously known to be expressed by adult human keratinocytes, was found at considerable levels in these analyses. In this paper we report the skin-speci®c expression of cystatin M/E, and its induction by serum in vitro using cultured human keratinocytes. We demonstrate that cystatin M/E is a secreted protein and, in addition to its reported antiproteinase activity, has at least one additional biologic property by acting as an acyl acceptor in TGase-mediated reactions, thereby becoming a structural part of the CE.
MATERIALS AND METHODS

Keratinocyte culture
Human keratinocytes were obtained from shave biopsies of adult epidermis (lower back) and were primary cultured according to the Rheinwald±Green system (Rheinwald and Green, 1975) . First passage cells were seeded in keratinocyte growth medium (KGM; Biowhittaker, Walkersville, MD) as described by . Differentiation of keratinocytes was induced by switching con¯uent keratinocyte cultures for 72 h to KGM supplemented with 5% fetal bovine serum (FBS).
Cloning of cystatin M/E in baculovirus
Based on the cDNA sequence of cystatin M/E (Sotiropoulou et al, 1997) we designed two oligonucleotide primers that could amplify a partial cDNA, encoding amino acid residue Pro 23 to the stop codon at position 150 (cystatin M/ E forward primer, 5¢-GAAGATCTCCACGCGATGCCCG-3¢; cystatin M/E reverse primer, 5¢-CGGAATTCTCACATCTGCACACAG-3¢), excluding the amino acid residues corresponding to the hydrophobic signal peptide (Sotiropoulou et al, 1997) . Polymerase chain reactions (PCR) were carried out using a DNA thermal cycler (PTC-200, Biozym, Landgraaf, The Netherlands) in 25 ml mixtures. The following buffer conditions were used: 10 mM Tris-HCl, pH 9.0, 1.5 mM magnesium chloride, 50 mM potassium chloride, 0.1% Triton X-100, all four dNTPs (each at 200 mM), 1 unit of Taq DNA Polymerase (Promega, Madison, WI), and 20 pmol of each primer. After an initial incubation of 6 min at 94°C ampli®cation was conducted for one cycle of 1 min at 94°C, 1 min at 47°C, and 2 min at 72°C, followed by 34 cycles with an annealing temperature of 60°C. An additional 10 min at 72°C was used for the last cycle. As template for the PCR we used cystatin M cDNA (Sotiropoulou et al, 1997) . The ampli®ed fragment was cloned in frame into the pFastbac-HTb baculovirus expression vector, a component of the Bac-to-Bac Baculovirus Expression System (Life Technologies). After the recombinant pFastbac-HTb donor plasmid has been determined to be correct, the DNA is transformed into competent DH10Bac Escherichia coli cells for transposition into a baculovirus shuttle vector (bacmid), according to the protocol provided by the manufacturer. High molecular weight mini-prep DNA is prepared from selected E.coli clones containing the recombinant bacmid. These clones were screened for the presence of the desired sequences, and then used to transfect insect cells.
Production of recombinant baculovirus
Recombinant bacmid was transfected into Spodoptera frugiperda (Sf9) cells using Celfectin Reagent (Life Technologies) according to the protocol provided by the manufacturer, followed by infection of insect cells with recombinant baculovirus particles. The infected cells were harvested and lyzed, the cell debris was removed by centrifugation, and the supernatant, which contains the recombinant (His) 6 -tagged cystatin M/E protein, was stored at 4°C.
Puri®cation of recombinant cystatin M/E We puri®ed recombinant cystatin M/E with a Tris-based buffer system according to the protocol provided by the manufacturer (Bac-to-Bac Baculovirus Expression System, Life Technologies), with the exception that 2-mercaptoethanol and glycerol were omitted from all buffer solutions. To obtain recombinant cystatin M/E without the polyhistidine tag, the baculovirus expressed protein was digested with tobacco etch virus (TEV) proteinase according to the protocol provided by the manufacturer (Life Technologies).
Production and puri®cation of recombinant glutathione Stransferase (GST)±cystatin M/E The recombinant plasmid pGEX-2T/cystatin M/E was used to produce and purify recombinant GST± cystatin M/E fusion protein as described previously (Sotiropoulou et al, 1997) . To obtain recombinant cystatin M/E without the GST tag, the bacterially expressed fusion protein was digested with thrombin according to the protocol provided by the manufacturer (Sigma).
Polyclonal antibodies
The puri®ed GST±cystatin M/E fusion protein was used to immunize a New Zealand White rabbit and a Duncan Hartley guinea pig, which was carried out at the Central Animal Laboratory, University of Nijmegen, The Netherlands. Antisera raised against the GST±cystatin M/E fusion protein were puri®ed by af®nity chromatography using recombinant fusion protein coupled to CNBractivated Sepharose 4B (Pharmacia Biotech).
Autopsic material, skin biopsies, and tape stripping Autopsic material was obtained from the Department of Pathology, University of Nijmegen, The Netherlands. The following tissues were studied with respect to cystatin M/E expression: skin, tongue, gingiva, palatum, pharynx, nasal cavity, sole of the foot, esophagus, ileum, colon, stomach, bronchus, lung, trachea, ureter, kidney, bladder, pancreas, liver, heart, spleen, skeleton muscle, lymph node, aorta, cartilage, mammary gland, and uterus. Biopsies of normal skin and from psoriatic lesions were taken under local anesthesia with a keratome as described by Alkemade et al (1994) .
Immunohistochemistry (IHC)
Human skin biopsies and autopsic material were processed for IHC as previously described (Latijnhouwers et al, 1996) . The sections were subsequently incubated with af®nity-puri®ed polyclonal rabbit anticystatin M/E antibodies at a 1:50 dilution followed by IHC staining as described previously (Latijnhouwers et al, 1996) .
RNA isolation
Total RNA from human cultured keratinocytes and human tissues was isolated with RNA extraction solution (Wingens et al, 1999) . mRNA was isolated using the Quickprep Micro mRNA Puri®cation Kit (Pharmacia Biotech), according to the manufacturer's protocol.
Reverse transcriptase PCR (RT-PCR) ampli®cation of the cystatin M/E transcript
First strand cDNA was generated from mRNA as described previously (Zeeuwen et al, 1997) . The reverse transcriptase reaction products were used for PCR ampli®cation to obtain the cDNA of cystatin M/E and the housekeeping gene human acidic ribosomal phosphoprotein P0 (hARP). We designed oligonucleotide primers that could amplify the cystatin M/E cDNA including the ATG start codon and the TGA stop codon. These oligonucleotide sequences (®rst sense then antisense) for the cystatin M/E PCR were 5¢-TCC-GACGGCACTGACGGC-3¢ and 5¢-CCAATGGCCTTCGCCCTCG-3¢. The oligonucleotide sequences (®rst sense then antisense) to generate hARP cDNA were 5¢-ATGTGAAGTCACTGTGCC-3¢ and 5¢-ACC-AAATCCCATATCCTC-3¢. PCR were carried out using a DNA thermal cycler (TB1, Biometra, Go Èttingen, Germany) in 25 ml mixtures. The following buffer conditions were used: 10 mM Tris-HCl, pH 9.0, 1 mM magnesium chloride, 50 mM potassium chloride, 0.1% Triton X-100, all four dNTPs (each at 200 mM), 1 unit of Taq DNA Polymerase (Promega), and 20 pmol of each primer. After an initial incubation of 6 min at 94°C ampli®cation was conducted for 35 cycles as follows: 1 min at 94°C, 1 min at annealing temperature, and 2 min at 72°C. An additional 10 min at 72°C was used for the last cycle. Annealing temperatures were 58°C when using the cystatin M/E primers and 47°C for the hARP primers. PCR products were analyzed by agarose gel electrophoresis.
Northern blot analysis
Northern blot analysis was carried out as described by van Ruissen et al (1996) . Cystatin M/E cDNA (Sotiropoulou et al, 1997) and hARP cDNA were labeled with (a-32 P)dCTP using the Oligolabeling Kit (Pharmacia Biotech) according to the protocol provided by the manufacturer.
Analysis of cystatin M/E inhibitory activity by enzyme assays Papain and cathepsin B assay
Proteinase inhibitory activity of recombinant cystatin M/E was determined by measuring the inhibition of papain (Sigma) and cathepsin B (ICN Pharmaceuticals, Costa Mesa, CA) essentially described by Abrahamson (1994) , using the¯uorogenic synthetic substrate Z-Phe-Arg-AMC (Sigma). Papain/cathepsin B was titrated in the absence and presence of increasing concentrations of recombinant cystatin M/E. Cathepsin C assay Extracts of normal human skin were tested for cathepsin C activity by measuring the hydrolysis of¯uorogenic substrate H-Gly-Phe-AMC (Bachum, Bubendorf, Switzerland) using a modi®ed protocol (Toomes et al, 1999) . The amount of¯uorescence signal produced from the substrate by skin extract was measured in sodium phosphate buffer (0.1 M, pH 5.5) containing 100 mM NaCl and 2 mM dithiothreitol. Substrate hydrolysis was measured after an incubation of 30 min at 37°C. Skin extract (containing cathepsin C) was titrated in the absence and presence of increasing concentrations of recombinant cystatin M/E.
Enzyme-linked immunosorbent assay (ELISA) for measurement of cystatin M/E levels
Cystatin M/E concentrations were measured in supernatant of cultured keratinocytes and human sweat and nasal mucus, using a sandwich-type ELISA. Microtiter plates (96¯at bottom wells) were coated overnight with puri®ed rabbit anticystatin M/E antiserum [1:1600 dilution in phosphate-buffered saline (PBS)]. The incubation steps in this protocol are carried out for 45 min at 37°C, and every incubation step in the protocol is followed by a washing step with PBS containing 0.05% Tween-20 (Biorad, Richmond, CA). After washing, the microtiter plates were blocked with bovine serum albumin (BSA, 10 mg per ml in PBS) with 1% normal goat serum and probed with dilutions of test samples and standards (recombinant baculovirus expressed cystatin M/E). As second antibody we used guinea pig anticystatin M/E antiserum (1:6400 dilution in PBS, 0.05% Tween-20, 0.1% BSA) with 1% normal rabbit serum. Subsequently, the microtiter plates were incubated with biotinylated goat antiguinea pig IgG (Vector Laboratories, Burlingame, CA) with 1% normal rabbit serum, followed by an incubation with the ABC complex. Finally o-phenylenediamine dihydrochloride (Pierce, Rockford, IL) was added as chromogenic substrate for 15 min at room temperature. This enzyme reaction was stopped by the addition of 4 M H 2 SO 4 . Data were read with a Biorad ELISA reader at 492 nm and at 655 nm.
Antimicrobial assays Puri®ed recombinant cystatin M/E (baculovirus-expressed) without the polyhistidine tag was tested for antimicrobial activity against the bacterium Staphylococcus aureus 42D and the yeast Candida albicans UC 820 in an antimicrobial assay as described previously (Wingens et al, 1998) . Recombinant SLPI (a kind gift of Dr. R.C. Thompson, Synergen, Boulder, CO) and cystatin C (a gift from the Department of Oral Biochemistry, VU Amsterdam, The Netherlands) were used in comparison experiments with cystatin M/E.
Preparation of protein extracts
Normal skin and epidermal scales from a psoriatic patient were homogenized in buffer containing 50 mM Tris-HCl, pH 7.8, and 100 mM sodium chloride. The protein extracts were centrifuged for 30 min at 25,000 Q g and the supernatant was subsequently dialyzed against PBS and stored at ±20°C until further use.
Cross-linking of cystatin M/E to stratum corneum proteins by endogenous TGase
For cross-linking experiments 200 mg proteins from a psoriatic scale extract were used with 2 mg of baculovirusexpressed puri®ed recombinant cystatin M/E. Buffer and reaction conditions were as previously described (Zeeuwen et al, 1997) . Reaction mixtures containing 20 mM ethylenediamine tetraacetic acid (EDTA), pH 7.8, were used as controls. The reaction mixtures were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and electroblotted onto polyvinylidenedi¯uoride (PVDF) membrane (Millipore, Bedford, MA). The membrane was incubated with af®nity-puri®ed polyclonal rabbit anticystatin M/E antibodies at a 1:15,000 dilution. This step was followed by incubation with swine antirabbit horseradish peroxidase (SWARPO; Dako, Glostrup, Denmark) at a 1:1000 dilution. Cross-linked cystatin M/E was detected with the Phototope-HRP Western Blot Detection Kit (New England Biolabs, Beverly, MA). This assay uses LumiGLO chemiluminescent reagent and peroxide. The light emitted by destabilized LumiGLO reagent is subsequently captured on X-Omat S1 ®lms (Kodak), and processed using the Imagemaster data image system (Pharmacia).
Cross-linking of biotinylated peptides to cystatin M/E by exogenous TGase
Four hexapeptides, based on the TGase substrate motif of human SKALP/ela®n (Zeeuwen et al, 1997) , with an NH 2 -terminal biotin followed by a C6-spacer were synthesized: GQDPVK, GQDPVR, GNDPVK, and GNDPVR (Eurosequence, Groningen, The Netherlands). For cross-linking experiments 6 mg of baculovirusexpressed puri®ed recombinant cystatin M/E was used with 0.5 mg of biotinylated peptide and 3 ml (0.0313 units per ml) of guinea pig liver TGase (Sigma). The reaction mixtures were blotted directly onto PVDF membranes by a slot blot manifold. The membrane was incubated with an HRP-linked antibiotin antibody, and biotinylated proteins were detected with the Phototope-HRP Western Blot Detection Kit as described above.
Puri®cation of cystatin M/E from human skin
Af®nity-puri®ed polyclonal rabbit anticystatin M/E antibody was coupled to CNBractivated Sepharose 4B, and this antibody±agarose conjugate was subsequently used to purify the native cystatin M/E protein from psoriatic scale extracts according to the protocol provided by the manufacturer. The collected proteins were subjected to SDS-PAGE and electroblotted onto PDVF membrane. The membrane was incubated with af®nity-puri®ed polyclonal rabbit anticystatin M/E and native cystatin M/E was detected with the Phototope-HRP Western Blot Detection Kit as described above.
SDS-PAGE and western blotting
Samples (TGase assay reaction mixtures, puri®ed native protein) were diluted with SDS sample buffer (containing dithiothreitol) and boiled for 2 min. These protein samples were separated by SDS-PAGE on a 15% Tris-glycine Ready gel (Biorad) using Tris-glycine as electrophoresis buffer (Laemmli, 1970) . VOL. 116, NO. 5 MAY 2001 
RESULTS
Cystatin M/E is expressed by epidermal keratinocytes in vitro and in vivo Keratinocyte gene expression was comprehensively examined by means of SAGE on cultured human keratinocytes. In our SAGE library a total of 25,694 tags were analyzed, corresponding to 10,224 genes, many of which were not known to be expressed in keratinocytes (for details of this analysis see Jansen et al, 2001) . A large number of keratinocyte-speci®c transcripts, coding for proteins involved in epidermal differentiation and skin barrier function, were identi®ed (6% of all transcripts). Surprisingly, a signi®cant part of the identi®ed transcripts accounted for genes involved in host protection such as antimicrobial proteins and proteinase inhibitors (2% of all transcripts). High expression levels were found for members of the cystatin family, SLPI and SKALP/ela®n. Cystatin M/E, a recently described family 2 cystatin not previously known to be expressed by adult human keratinocytes, was found at intermediate levels in the SAGE library of cultured keratinocytes (0.04% of all transcripts). On the basis of its expression in our SAGE library we decided to investigate whether cystatin M/E was also expressed in human skin in vivo. Af®nity-puri®ed polyclonal antibodies against recombinant cystatin M/E were used for a comprehensive expression study on a large panel of human tissues (see Materials and Methods for a complete list of tissues examined). We found that cystatin M/E showed a tissue-speci®c expression pattern that was limited to epithelial cells in skin and nasal cavity. Figure 1 shows the immunolocalization of cystatin M/E in these tissues. In normal, nonpalmoplantar skin, cystatin M/E is highly expressed in the stratum granulosum and weakly in the spinous layers (Fig 1a) . Positive staining for cystatin M/E in several (®ve to seven) layers of suprabasal spinous cells was seen in psoriatic lesional skin (Fig 1b) , whereas the granular cells are not stained as strongly as in normal skin. Differentiated keratinocytes of the infundibular epithelium of the hair follicle were also found to be positive for cystatin M/E (Fig 1c) . In plantar skin, positive staining for cystatin M/E was seen in several layers of the suprabasal spinous cells (Fig 1d) , which resembles the pattern in psoriatic skin. In the epidermis of the foot sole, a duct of a sweat gland is positively stained for cystatin M/E (Fig 1d, arrowhead) . The secretory coils of eccrine sweat glands that are found in the deep dermal part of the foot sole (Fig 1e) are also positively stained for cystatin M/E (arrow). In contrast with the epidermal part of the sweat gland duct, the dermal part of the duct is almost negative (arrowheads). A slight cystatin M/E staining is found in mucous glands in the nasal cavity (Fig 1f, arrows) . No expression of cystatin M/E was seen in any of the other human tissues examined by IHC (data not shown). To examine the expression at the mRNA level we performed RT-PCR analysis on almost the same panel of human tissues. As shown in Fig 2, this analysis con®rmed that cystatin M/E gene expression is restricted to human skin, which is demonstrated by the 496 bp PCR product, generated using cystatin M/E speci®c oligonucleotides. Sequencing of this 496 bp product was performed to verify that it was indeed cystatin M/E. Because the availability of the mRNA of the various tissue samples was limited, we could not perform northern blot analysis on all of them, which would give a more quantitative measure for mRNA levels. Northern blot analysis was performed on skin biopsies (n = 7), foot sole (n = 1), oral epithelia (n = 1), and peripheral blood leukocytes (n = 5), which revealed a strongly hybridizing band of 0.6 kb in the lanes loaded with RNA from skin (Fig 3, lanes 1±7) . A weak signal was seen in foot sole but this lane was clearly underloaded compared to normal skin (lane 8), whereas oral epithelia (lanes 9±11) and all blood samples were negative for cystatin M/E (lanes 12±16).
Isolation and characterization of recombinant cystatin M/E To further investigate the functional properties of cystatin M/E we produced recombinant protein, both in a bacterial expression system as a GST fusion protein and as a fully processed protein (lacking the signal peptide) in an eukaryotic system using the baculovirus in insect cells. The puri®ed GST fusion protein was detected on SDS-PAGE as a single~40 kDa band as previously described (Sotiropoulou et al, 1997) (Fig 4, lane  1) . Cystatin M/E cleaved from the GST±cystatin M/E fusion protein by thrombin migrates with an apparent size of~14 kDa (Fig 4, lane 2) . The puri®ed baculovirus-expressed protein was found on SDS-PAGE as a doublet of, respectively,~14 and 16 kDa, where the upper band was suspected to be a glycosylated species of cystatin M/E (Ni et al, 1997) (Fig 4, lane 3) . To test whether both recombinant proteins are functional proteinase inhibitors, cystatin M/E inhibitory activity was measured by titration of papain activity in the absence and presence of increasing concentrations of inhibitor, as described by Sotiropoulou et al (1997) . It was found that baculovirus expressed (not shown) and bacterially expressed cystatin M/E both displayed inhibitory activity against the cysteine proteinase papain. The inhibitory activity of cystatin M/E cleaved from the GST±cystatin M/E fusion protein is shown in Fig 5. Papain hydrolysis of the¯uorogenic substrate Z-Phe-Arg-AMC was almost completely inhibited in the presence of 5 nM cystatin M/E (Fig 5a) , whereas recombinant GST did not have any effect on papain activity (not shown). Using the same assay we found a moderate inhibitory activity against cathepsin B as cystatin M/E was used up to micromolar concentrations (Fig 5b) . As de®ciency for cathepsin C was recently described to be the cause of Papillon±Lefe Ávre syndrome (Hart et al, 1999) , cathepsin C is likely to be an important proteinase for epidermal homeostasis. For this reason we were interested to know if cystatin M/E could inhibit cathepsin C. Based on the pH-dependent activation of cathepsin C by chloride ions (Cigic and Pain, 1999) , and using a cathepsin C speci®c synthetic substrate (H-Gly-Phe-AMC), we could demonstrate the presence of cathepsin C in normal human skin extracts. No inhibition of substrate hydrolysis could be detected, however, in the presence of increasing amounts of recombinant cystatin M/E (Fig 5c) . In addition to its proteinase inhibitory activity, we tested cystatin M/E for possible direct antimicrobial activity as was described for other known proteinase inhibitors. Recombinant baculovirus expressed cystatin M/E, which was digested with TEV proteinase to remove the polyhistidine tag, showed no detectable bacterial killing against the tested gram-positive bacterium S. aureus, whereas SLPI, a wellknown broad-range antimicrobial protein, effectively inhibits growth of this bacterium (data not shown). Additionally, the growth of C. albicans was completely inhibited by SLPI, whereas cystatin M/E and cystatin C appeared to be ineffective.
Cystatin M/E is a target for cross-linking by TGase
The expression pattern of cystatin M/E raised the possibility that this protein could be involved in barrier function in human skin. Furthermore, its presence in terminally differentiated keratinocytes as demonstrated with IHC suggested that it could be a structural part of the stratum corneum, e.g., by TGase-mediated cross-linking. In earlier work we reported that the serine proteinase inhibitor SKALP/ela®n possesses TGase substrate motifs that can act as an anchoring sequence to corni®ed envelope proteins (Zeeuwen et al, 1997) . To investigate if cystatin M/E is a possible substrate for TGase, we used biotinylated hexapeptide probes based on the TGase substrate motif of human SKALP/ela®n in cross-linking reactions that were catalyzed by exogenous tissue type 2 TGase. The TGase cross-linking reaction is based on a Ca 2+ -dependent exchange of primary amines for ammonia at the gcarboxamide group of glutamine residues. Peptide-bound lysine residues or polyamines serve as the primary amines to form either e-(g-glutamyl)lysine or (g-glutamyl)polyamine bonds between proteins (Folk and Finlayson, 1977) , which are highly resistant to chemical and enzymatic degradation (Folk, 1983) . Recombinant cystatin M/E was shown to be an ef®cient substrate for tissue type 2 TGase (Fig 6a) . Cross-linking was demonstrated using the GQDPVK hexapeptide (an acyl donor and acceptor probe) and the GQDPVR hexapeptide (an acyl donor probe). No cross-linking was observed, however, when the GNDPVK hexapeptide (an acyl acceptor probe) or GNDPVR hexapeptide (a probe in which both Q and K have been replaced, and which is no longer a TGase substrate) were used, indicating that cystatin M/E acts as an acyl acceptor. Speci®city was checked by the addition of excess EDTA, as a control for the Ca 2+ -dependent reaction (not shown). In addition to cross-linking of cystatin M/E to the biotinylated hexapeptides, we also used an aqueous extract of stratum corneum derived from a psoriatic patient as a source of natural substrate proteins and endogenous TGases (Fig 6b) . Analysis by SDS-PAGE showed incorporation of cystatin M/E in proteins predominantly between 30 and 100 kDa (lane 4), whereas the addition of excess EDTA prevents cross-linking of cystatin M/E (lane 5). Lane 3 is a blank of stratum corneum extract without cystatin M/E added. To check self cross-linking, recombinant cystatin M/E was incubated with exogenous TGase type 2 Figure 3 . Northern blot analysis of cystatin M/E expression in human tissues. Ten micrograms of total RNA were loaded and probed with 32 P-labeled cystatin M/E cDNA. hARP was used for control hybridization to check for equal mRNA loading. Lanes 1, 4, and 7 represent normal skin, and lanes 2, 3, 5, and 6 represent psoriatic skin. Foot sole (lane 8) and oral epithelia (lanes 9±11), which represent, respectively, tongue, gingiva, and pharynx, are negative for cystatin M/E expression. Also, several samples of RNA derived from peripheral blood leukocytes were negative for cystatin M/E (lanes 12±16). VOL. 116, NO. 5 MAY 2001 without the scale extract (lane 2), but no additional bands were detected.
Induction of cystatin M/E in cultured human keratinocytes
Two other epidermal host defense proteins that were recently described (SKALP/ela®n and SLPI) are known to be induced in differentiated cultures of epidermal keratinocytes (Wingens et al, 1998; Pfundt et al, 2000) . We investigated the induction of cystatin M/E by FBS, as we have previously shown that SKALP/ela®n and SLPI are both highly upregulated by FBS or normal human serum (Molhuizen et al, 1995) . We used culture systems that we have previously described that allow the induction of regenerative differentiation of keratinocytes by the addition of serum. Northern blot analysis (Fig 7) showed that cystatin M/E mRNA is strongly upregulated in these cultures. This induction was also found at the protein level as detected by ELISA on the supernatant of cultured keratinocytes. In undifferentiated keratinocytes we found no detectable amounts of cystatin M/E in the supernatant, whereas the supernatant of differentiated keratinocytes contained signi®cant levels of cystatin M/E (85 ng per ml).
Cystatin M/E is a secreted protein in vitro and in vivo Based on the hydrophobic amino acid N-terminal sequence of cystatin M/E (Sotiropoulou et al, 1997) , coding for a putative signal peptide, it was supposed that cystatin M/E could be secreted. As mentioned in the previous paragraph, cystatin M/E was found to be secreted in vitro in the supernatant of cultured keratinocytes. We also demonstrated by ELISA that cystatin M/E is secreted in vivo in human sweat and in low amounts in nasal mucus (respectively 88 and 7 ng per ml). These results were con®rmed by western blot analysis, which showed a single~14 kDa band of cystatin M/E in concentrated (5Q) culture supernatant of differentiated keratinocytes and concentrated human sweat (Fig 8, lanes 2±3) , whereas in concentrated culture supernatant of undifferentiated keratinocytes no cystatin M/E could be detected (Fig 8, lane 1) . For comparison, recombinant cystatin M/E cleaved from the fusion protein was run on the gel (Fig 8, lane 4) . We could also detect native cystatin M/E in psoriatic scale extracts, which was puri®ed by af®nity chromatography (Fig 8, lane 5) .
DISCUSSION
SAGE is an ef®cient and comprehensive approach to examining cellular gene expression pro®les, as we have recently done on cultured human keratinocytes (Jansen et al, 2001) . Using this technique we have identi®ed a number of new genes, and several genes not previously known to be expressed in epidermis. One of these, cystatin M/E, is characterized in this paper. We show by IHC that cystatin M/E protein expression in vivo is largely restricted to human skin. This observation is an apparent discrepancy with previous studies, which have reported expression of cystatin M/E at the mRNA level in several other human tissues (Ni et al, 1997; Sotiropoulou et al, 1997) . These two papers, however, are also contradictory with respect to the observed expression in tissues such as brain, liver, and peripheral blood leukocytes. A possible explanation for the inconsistencies between these two papers is a difference between expression at the mRNA and protein level. We have found, however, that northern blotting and RT-PCR analysis on mRNA extracted from fresh autopsy and biopsy material con®rms the speci®c expression of cystatin M/E in human skin. It is therefore likely that additional, hitherto unidenti®ed transcripts with high similarity to the cystatin M/E probe are present in specialized tissues (Ni et al, 1997) . This assumption is plausible considering that transcripts larger in size than 0.6 kb were found by northern blot analysis (Sotiropoulou et al, 1997) , and it was not clear whether these transcripts originate from cystatin M/E or from a closely related gene.
High cystatin M/E expression at the protein level was found only in the stratum granulosum of normal skin, in hair follicle, and in eccrine sweat glands. In psoriatic skin an increased number of cystatin M/E positive cells was found, possibly resulting from in¯ammatory cytokines that are known to induce abnormal differentiation (Pfundt et al, 2000) . Cysteine proteinases and their endogenous inhibitors are known to be present in human eccrine sweat (Yokozeki et al, 1991) , and cystatin M/E could be one of the natural inhibitors. The constitutive expression could be explained by high levels of cytokines, which are present in normal human skin eccrine sweat gland duct and secretory coil epithelium (Boehm et al, 1994) . Further regulatory features of cystatin M/E and the possible involvement of in¯ammatory cytokines remain to be investigated, however.
Both in vivo and in vitro we found that cystatin M/E is a secreted protein. Using IHC, however, we could demonstrate high levels within the cells. In addition, the ®nding that cystatin M/E could be cross-linked to stratum corneum proteins, a process that occurs within the cell during terminal differentiation, opens the possibility that cystatin M/E also acts within the cell. Although these ®ndings appear paradoxical, similar data have been reported for SKALP/ ela®n and SLPI, two other secreted epidermal proteinase inhibitors. SKALP/ela®n, which is secreted into the extracellular space, was found to be cross-linked to loricrin and other corni®ed envelope components (Steinert and Marekov, 1995) , and ultrastructurally it was found in granules other than secretory lamellar granules (Pfundt et al, 1996) . SLPI, a secreted proteinase inhibitor, is known to interfere with lipopolysaccharide signaling (Jin et al, 1997) , but rather surprisingly it was recently shown that SLPI acts intracellularly rather than extracellularly (Zhu et al, 1999) . By analogy, these ®ndings leave open the possibility that cystatin M/E has multiple functions, both intracellularly and extracellularly.
The presence of cystatin M/E in the stratum granulosum opens the possibility that this molecule has a role in the physical barrier of human skin formed by the stratum corneum. The protective callus layer resulting from terminal differentiation of the squamous epithelium is thought to be cross-linked by different TGase activities present in mammalian epidermis. Four TGases (TGase 1, 2, 3, and X) are known to be expressed in the epidermis (Greenberg et al, 1991; Kim et al, 1991; Steinert and Marekov, 1995; Aeschlimann et al, 1998) , but thus far only limited data are available with respect to their substrate speci®cities and relative contributions in CE assembly. In vitro, we have shown that cystatin M/E is an ef®cient substrate for tissue type 2 TGase in cross-linking reactions with biotinylated hexapeptides. Crosslinking of the biotinylated GQDPVK and GQDPVR hexapeptides to recombinant cystatin M/E was observed, but substitution of the acyl donor residue glutamine (Q) for asparagine (N) totally abolished cross-linking of the biotinylated GNDPVK and GNDPVR hexapeptides. From these results we can surmise that cystatin M/E acts as an acyl acceptor but not as acyl donor. We could not detect oligomerization of recombinant cystatin M/E in a reaction with exogenous TGase 2, suggesting that the glutamine (Q) residues of cystatin M/E do not take part in the cross-linking reaction catalyzed by TGase 2. VOL. 116, NO. 5 MAY 2001 Desquamation is the ®nal event in terminal differentiation of the epidermis, which occurs by the action of proteolytic enzymes. During desquamation there is proteinase-mediated breakdown of the desmosomal cohesive complexes that link the corneocytes (Lundstrom and Egelrud, 1990a, b; Suzuki et al, 1994) . There is some evidence indicating that stratum corneum chymotryptic enzyme (SCCE), a serine proteinase, is responsible for the degradation of desmosomes leading to desquamation (Egelrud and Lundstrom, 1991; Hansson et al, 1994) . Recently the inhibition of SCCE by SLPI was described, which may be of importance in the regulation of epidermal homeostasis (Franzke et al, 1996) . Besides other stratum corneum serine proteinases that have been implicated in desquamation (Suzuki et al, 1993; Brattsand and Egelrud, 1999; Ekholm et al, 2000) , recently an aspartic proteinase, cathepsin D, was found that appears to be associated with the ®nal stage of desquamation (Horikoshi et al, 1999) . Lysosomal cysteine proteinases such as cathepsin B and L are known to be expressed in the basal and spinous layers of normal skin mainly as inactive precursors. These proteins were processed to activated mature enzymes in psoriatic epidermis (Kawada et al, 1997) , where they are thought to be involved in the keratinization process. Cystatin M/E is a moderately active inhibitor of cathepsin B, which indicates that this cysteine proteinase inhibitor could have a possible function in the regulation of keratinization and desquamation. It is more likely, however, that the target protein for cystatin M/E is found in the extracellular space as it could be secreted. Interestingly, a new cysteine proteinase of late epidermal differentiation, stratum corneum thiol proteinase (SCTP), was recently described by Watkinson (1999) , and could be a possible target enzyme for cystatin M/E. SCTP appears to be a speci®c product of differentiated keratinocytes, and furthermore it is apparently not stored within these cells but is actively secreted. A role for SCTP in degradation of extracellular stratum corneum substrates, which have been linked with the desquamatory process, and its possible regulation by cystatin M/E remain to be explored.
Finally, in addition to a role in regulation of endogenous proteinases, it is conceivable that cystatin M/E is involved in regulation of exogenous proteinases derived from the commensal skin¯ora or potential skin pathogens. Although we could not demonstrate a direct microbicidal effect in vitro, it is very possible that microbial proteinases involved in skin colonization and invasion are targets for cystatin M/E. Clearly, identi®cation of potential microbial target proteins or generation of cystatin M/E knockout mice could shed further light on the biologic function of this molecule and its presumed role in epidermal homeostasis.
